Are Endothelial Cell-Derived Microparticles Predictive Biomarkers inCardiovascular Diseases?
Received Date: Sep 14, 2015 / Accepted Date: May 16, 2016 / Published Date: May 23, 2016
Endothelial dysfunction is involved in the various stages of cardiovascular (CV) disease development. Microparticles (MPs) originated from endothelial cells as biological markers of endothelial injury and repair could appear sufficient predictor of clinical outcomes and probable they might use in biomarker-guided therapy. Apoptotic endothelial cell-derived MPs are able to directly mediate a microvascular inflammation and worsening of endothelial integrity. In contrast, endothelial MPs originated from activated endothelial cells might contribute vascular repair and vasodilatation. It has been suggested that endothelial cells release phenotypically and quantitatively distinct endothelial MPs in activation and apoptosis, and that the phenotype of MP pattern can provide useful information reflecting the nature of endothelial injury. Editorial comment is discussed the role of impaired immune pattern of circulating endothelial cell-derived MPs as a personalized marker of vascular remodelling or endothelial dysfunction among CV disease persons.
Keywords: Cardiovascular disease; Endothelial dysfunction; Endothelial cell-derived micro particles; Clinical outcomes; Prediction
Select your language of interest to view the total content in your interested language
Share This Article
April 19-20, 2018 Amsterdam, Netherlands
May 14-16, 2018 Tokyo, Japan
June 11-13, 2018 Barcelona, Spain
August 09-10, 2018 Manila, Philippines
September 21-22, 2018 Vancouver, Canada
- Total views: 11898
- [From(publication date): 3-2016 - Dec 15, 2017]
- Breakdown by view type
- HTML page views: 8101
- PDF downloads: 3797